Drug X is useful in the treatment of rheumatoid arthritis. It is available only in the parenteral formulation and its mechanism of action is antagonism of tumor necrosis factor. Which of the following can be X?
## **Core Concept**
The question tests knowledge of biologic disease-modifying antirheumatic drugs (bDMARDs) used in the treatment of rheumatoid arthritis, specifically those that target tumor necrosis factor-alpha (TNF-alpha). These drugs are crucial in managing autoimmune diseases like rheumatoid arthritis by modulating the immune system.
## **Why the Correct Answer is Right**
The correct answer, , is a TNF-alpha inhibitor. TNF-alpha inhibitors are a class of biologic drugs that are used to treat autoimmune diseases such as rheumatoid arthritis by blocking the action of TNF-alpha, a substance in the body that causes inflammation. is administered parenterally, which aligns with the details provided in the question.
## **Why Each Wrong Option is Incorrect**
* **Option A:** is not a TNF-alpha inhibitor; it works by inhibiting interleukin-1 (IL-1), another cytokine involved in inflammation. Therefore, it does not match the mechanism of action described.
* **Option B:** is a Janus kinase (JAK) inhibitor. It works by blocking certain enzymes (JAK1 and JAK3) that are involved in the signaling pathways of cytokines, which are molecules that promote inflammation. This does not align with the TNF-alpha antagonism mechanism described.
* **Option C:** is incorrect because although it is used in rheumatoid arthritis, its primary mechanism does not involve TNF-alpha antagonism.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that TNF-alpha inhibitors, like , are critical in the management of rheumatoid arthritis and are associated with an increased risk of infections due to their immunosuppressive effects. Clinicians must screen patients for latent tuberculosis before initiating therapy.
## **Correct Answer:** . Etanercept